Patent ID: 11918724
Assignee: FRESENIUS MEDICAL CARE DEUTSCHLAND GMBH
Field: Medical technology (Instruments)
Classification: CPC A  Y | IPC A

Claim 11:
12. A blood treatment apparatus for an extracorporeal blood treatment, comprising:
at least one control device configured to effectuate a blood treatment of a patient by activating a blood pump of the blood treatment apparatus to: (i) withdraw blood from a patient, (ii) convey the blood through an extracorporeal blood circuit connected to the patient, and (iii) return the blood to the patient,
wherein the control device is configured: (i) to be activated or controlled in order to temporarily interrupt the blood treatment being effected by the blood treatment apparatus or (ii) to effect a temporary interruption of the blood treatment apparatus,
wherein the control device is configured to, while the blood treatment is temporarily interrupted and while the blood treatment apparatus is disconnected from the patient and while blood of the patient is in the extracorporeal blood circuit, induce a first connection of an arterial line section of the extracorporeal blood circuit to a source of substituate and a second connection of a venous line section of the extracorporeal blood circuit to the source of substituate, or configured to advise a user to make the first connection of the arterial line section and the second connection of the venous line section of the extracorporeal blood circuit to the source of substituate;

wherein the control device is further configured to, while the blood treatment is temporarily interrupted and while the blood treatment apparatus is disconnected from the patient and while the blood of the patient is in the extracorporeal blood circuit, activate the blood pump to induce or effect a circulation of at least one substituate liquid supplied from the source of substituate in the extracorporeal blood circuit;
wherein the control device is further configured to transition the blood treatment apparatus to subsequently continue the blood treatment after the blood treatment is temporarily interrupted, the blood treatment apparatus being reconnected to the patient prior to continuing the blood treatment;
wherein the control device functionally interacts with the blood treatment apparatus;
wherein, in response to temporarily interrupting the treatment, the control device is configured to automatically change or deactivate, during the temporary interruption of the blood treatment, (i) threshold windows of parameters or (ii) monitoring processes, wherein the threshold windows of parameters or the monitoring processes are set or used during the blood treatment; and
wherein the control device is configured to automatically deactivate monitoring processes during the temporary interruption of the blood treatment.